Iloprost for the treatment of bone marrow edema in the hindfoot.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 14719835.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The parenteral application of the vasoactive drug, iloprost, might be a viable option for the treatment of BMES of different origins, especially ischemic ones. In edema that is secondary to osteoarthrosis or stress, the effect of therapy with iloprost depends on the grade of the basic disease. The natural course of the disease, as well as the normalization of the signal pattern of the MRI, seem to be accelerated.
Medical subject headings
- Bone Marrow Diseases
- Edema
- Foot Diseases
- Iloprost
- Vasodilator Agents
Anatomy
- foot